Nisa Investment Advisors
KRYS icon

Nisa Investment Advisors’s Krystal Biotech KRYS Stock Holding History

Nisa Investment Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Buy
937
+7
+0.8% +$1.86K ﹤0.01% 1153
2025
Q4 		$229K Buy
930
+4
+0.4% +$842 ﹤0.01% 1202
2025
Q3 		$163K Buy
926
+40
+5% +$5.99K ﹤0.01% 1298
2025
Q2 		$122K Sell
886
-34
-4% -$4.99K ﹤0.01% 1335
2025
Q1 		$166K Sell
920
-88
-9% -$14.8K ﹤0.01% 1275
2024
Q4 		$158K Buy
1,008
+37
+4% +$6.56K ﹤0.01% 1357
2024
Q3 		$177K Buy
971
+31
+3% +$5.98K ﹤0.01% 1305
2024
Q2 		$173K Buy
940
+94
+11% +$15.8K ﹤0.01% 1344
2024
Q1 		$151K Buy
846
+19
+2% +$2.64K ﹤0.01% 1376
2023
Q4 		$103K Sell
827
-100
-11% -$11.1K ﹤0.01% 1427
2023
Q3 		$108K Hold
927
– – ﹤0.01% 1482
2023
Q2 		$109K Sell
927
-50
-5% -$5.11K ﹤0.01% 1485
2023
Q1 		$78K Sell
977
-100
-9% -$7.86K ﹤0.01% 1579
2022
Q4 		$85K Hold
1,077
– – ﹤0.01% 1608
2022
Q3 		$82K Buy
1,077
+17
+2% +$1.23K ﹤0.01% 1570
2022
Q2 		$70K Buy
1,060
+800
+308% +$49.8K ﹤0.01% 1614
2022
Q1 		$17K Sell
260
-110
-30% -$6.87K ﹤0.01% 2091
2021
Q4 		$22K Hold
370
– – ﹤0.01% 1908
2021
Q3 		$19 Hold
370
– – ﹤0.01% 2103
2021
Q2 		$25 Buy
+370
New +$25.8K ﹤0.01% 2092

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nisa Investment Advisors's KRYS Position: Q1 2026 in Review

Nisa Investment Advisors increased its Krystal Biotech (KRYS) stake by 0.75% in Q1 2026, buying an estimated $1.86K and bringing the position to 937 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Nisa Investment Advisors first reported a position in KRYS in Q2 2021 and has held it in 20 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Nisa Investment Advisors held 937 shares of Krystal Biotech worth $242K as of Q1 2026.
  • Nisa Investment Advisors bought 7 Krystal Biotech shares in Q1 2026, an estimated $1.86K.
  • Krystal Biotech made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1153 holding.
  • Nisa Investment Advisors first reported a position in Krystal Biotech in Q2 2021 and has held it in 20 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.